Analystreport

ContraFect Corp (NASDAQ: CFRX) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $1.50 price target on the stock.

ContraFect Corporation  (CFRX) 
Last contrafect corporation earnings: 3/18 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.contrafect.com